Sensory processing deficits, first investigated by Kraepelin and Bleuler as possible
pathophysiological mechanisms in schizophrenia, are now being recharacterized in the …

Neuroimaging is central to the quest for a biological foundation of psychiatric diagnosis but
so far has not yielded clinically relevant biomarkers for mental disorders. This review …

Brain signals have been investigated within the medical field for more than a century to
study brain diseases like epilepsy, spinal cord injuries, Alzheimer's, Parkinson's …

Nitric oxide (NO) is a gaseous transmitter produced by nitric oxide synthases (NOSs). The
neuronal isoform (NOS‐I, encoded by NOS1) is the main source of NO in the central nervous …

Excessive alcohol consumption is involved in 1/10 of deaths of US working-age adults and
costs the country around $250,000,000 yearly. While Alcohol Use Disorder (AUD) pathology …

Currently, schizophrenia is considered a multifactorial disease. Over the past 50 years,
many investigators have considered the role of toxic free radicals in the etiology of …

According to the recent data, nitric oxide (NO) is a chemical messenger that mediates
functions such as vasodilation and neurotransmission, as well as displaying antimicrobial …

Visual processing studies have repeatedly shown impairment in patients with schizophrenia
compared to healthy controls. Electroencephalography (EEG) and, specifically, visual …

Neurophysiological investigations in patients with schizophrenia consistently show early
sensory processing deficits in the visual system. Importantly, comparable sensory deficits …

NO is a pleiotropic signaling molecule and has an important role in cognition and emotion.
In the brain, NO is produced by neuronal nitric oxide synthase (NOS-I, encoded by NOS1) …